DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 FemTech Market: With 100+ Startups in the domain, Women Healthcare is Witnessing a Huge Upliftment Visit Post
2 A Globally Rising Burden of Sexually Transmitted Diseases (STDs) Visit Post
3 AZ, Daiichi inks an oncology deal; Moderna begins Phase III trial of its COVID-19 vaccine; No good news for Solid's DMD gene therapy trial Visit Post
4 Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis and Chugai's Collaboration; A new study on averting heart attack Visit Post
5 Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipressin; Breast Cancer research update Visit Post
6 Spot the Signs and Fight Postpartum Depressions Visit Post
7 Lassen’s anti-IL-11 antibody; PTC’s COVID-19 trial; Lenzilumab's result; Orca raises $192M Visit Post
8 Precision Medicine: An emerging approach to conventional treatment Visit Post
9 Altering the course of Ovarian cancer with emerging therapies in the horizon Visit Post
10 AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development Visit Post
11 What is the link between Alzheimer's and Menopause? Visit Post
12 Amgen reveals price; Bardy raises $35.5M; Kiadis to Acquire CytoSen; Insitro lands a deal Visit Post
13 Where Women Healthcare Stands Visit Post
14 Notizia Visit Post
15 BREAST CANCER AWARENESS MONTH Visit Post
16 Clinical Visit Post
17 AbbVie Receives Approval; Kymriah Approved; Shire Gets USFDA Approval; NICE Rejects; Bristol-Myers Squibb’s Opdivo; Eisai and Merck Get USFDA Approval Visit Post
18 Regulatory Visit Post
19 Snippet : Endometriosis Visit Post
20 Roche’s Phase 2 data; Celgene and Bluebird’s CAR-T therapy; Regeneron/Sanofi gets results; Allergan on women’s health Visit Post
21 Business Cocktail Visit Post
22 Merck's Remicade; Sanofi, Regeneron set Kevzara; Novartis to sever; Teva puts women's health Visit Post
23 Tesaro puts AstraZeneca; XELJANZ® receives; Innovus nabs; Alexion brings Visit Post
24 GSK consolidates DT and TT vaccine, AZ gears up for FDA filing, Novartis comes up with flex pricing, Concordia reports loss Visit Post
25 Endometriosis : Understanding the complex disease Visit Post
26 NPPA slams; Japan Joins Trump; PCI Pharma Announces Expansion; Merck opens plant; Mylan and Biocon win Visit Post
27 Vulvovaginal Candidiasis Visit Post
28 Follicle Stimulating Hormone for treatment of Endometriosis Visit Post
29 FDA accepts; Keytruda takes lead; M Pharmaceutical develops; Merck Deploys Palantir Visit Post
30 Vasomotor Symptoms of Menopause-Emerging Therapies Visit Post